← Back
$RLMD All transactions

RELMADA THERAPEUTICS, INC.

▲ BUY
7 / 10

Conviction

$ Value

$113K

Shares

27,500

Price

$4

Filed

Dec 16

Why this score? (7/10)
  • Open market buy (+3)
  • C-suite insider (+2)
  • Director (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

TRAVERSA SERGIO

Title

Chief Executive Officer

CIK

0001565832

Roles

Director Officer

Transaction Details

Transaction Date

2025-12-15

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,300,000

Footnotes

The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. | Purchase prices range from $4.10 to $4.12 per share, inclusive. | The stock appreciation rights vest in 16 equal quarterly installments commencing on March 12, 2026.

Filing Info

Accession No.

0001213900-25-121974

Form Type

4

Issuer CIK

0001553643

TRAVERSA SERGIO's History

Date Ticker Type Value
2025-12-15 RLMD $113K
2025-12-12 RLMD A $0
2025-11-05 RLMD $600K
2025-08-28 RLMD $41K
2025-08-27 RLMD $87K
2025-08-26 RLMD $50K
2025-06-26 RLMD A $0
2025-05-20 RLMD $82K
2025-05-19 RLMD $15K
2025-05-16 RLMD $77K

Other Insiders at RLMD (90d)

No other insider activity at this issuer in the last 90 days.